Philippe Reix

Villeurbanne, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications

Transformations within cystic fibrosis model of care in the era of CFTR modulators: a Scoping Review.

Transformations within cystic fibrosis model of care in the era of CFTR modulators: a Scoping Review.

Journal: Respiratory medicine
Published: March 18, 2026

A Twist in the Tale: Antenatal Volvulus Following Fetal CFTR Modulator Therapy.

A Twist in the Tale: Antenatal Volvulus Following Fetal CFTR Modulator Therapy.

Journal: Pediatric pulmonology
Published: February 07, 2026

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Journal: Rhinology
Published: February 02, 2026

The role of imaging in the monitoring of cystic fibrosis

The role of imaging in the monitoring of cystic fibrosis

Journal: La Revue du praticien
Published: January 23, 2026

International Delphi consensus recommendations for the follow-up of children born to people with CF and exposed to CFTR modulators in utero or through breastfeeding; endorsed by the European Cystic Fibrosis Society.

International Delphi consensus recommendations for the follow-up of children born to people with CF and exposed to CFTR modulators in utero or through breastfeeding; endorsed by the European Cystic Fibrosis Society.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 19, 2026

Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: results from the real-world MODUL-CF study.

Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: results from the real-world MODUL-CF study.

Journal: ERJ open research
Published: November 14, 2025

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.

Journal: CPT: pharmacometrics & systems pharmacology
Published: October 24, 2025

Gut-lung microbial dynamics with lumacaftor/ivacaftor in children with cystic fibrosis: a prospective multicenter study.

Gut-lung microbial dynamics with lumacaftor/ivacaftor in children with cystic fibrosis: a prospective multicenter study.

Journal: Pediatric research
Published: August 05, 2025

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Journal: Frontiers in pharmacology
Published: July 07, 2025

Lung function in children undergoing allo hematopoietic stem cell transplantation before the age of six.

Lung function in children undergoing allo hematopoietic stem cell transplantation before the age of six.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: June 01, 2025

Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study.

Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study.

Journal: The Lancet. Respiratory medicine
Published: April 13, 2025

Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy.

Intervention mapping for the development of a new model of care for people with cystic fibrosis in the era of highly effective modulator therapy.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: April 03, 2025
Showing 1-12 of 129

Last Updated: 09/26/2026